IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS)

CUSIP: 462222100

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+1,474,732
Put/Call ratio
67%
SEC-reported price per share
$79.11
Number of holders
491
Value change
+$164,534,797
Number of buys
260
Open additional details 1 more signal available
Number of sells
184
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
166,460,189

Security key

462222100

Report period

Q4 2025

Institutions

491

Top holders

10

Ownership snapshot

Top reported holders of IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
FMR LLC
Comparable rows
2/15
Latest evidence
30 Sep 2025
13F 13D/G Lead comparable stake: 5.7% 13 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 5.7%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 2
BlackRock, Inc. 5.7%
WELLINGTON MANAGEMENT GROUP LLP 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
5.7%
Reported 13D/G · 31 Mar 2025
$683,504,235
10,447,940 shares
— 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP
13F 13D/G
Company
4.3%
Reported 13D/G · 30 Jun 2025
$431,040,015
6,588,811 shares
— 30 Sep 2025
FMR LLC
13F
Company
13F
—
denominator unverified
$1,549,736,866
23,689,038 shares
— 30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,078,234,776
16,481,730 shares
— 30 Sep 2025
T. Rowe Price Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$860,727,000
13,156,929 shares
— 30 Sep 2025
Capital World Investors
13F
Company
13F
—
denominator unverified
$832,320,866
12,722,728 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
491
Shares
170,226,720
Rows available
491
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
433
Q4 2025 holders
491
Holder diff
58
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .